The SEC has asked the Hyderabad-based vaccine manufacturer to submit its revised protocol for trials
5 Jan 2022 1:15 PM IST
The suspension is in response to the outcomes of its post Emergency Use Authorisation inspection held between March...
3 April 2022 1:07 PM IST
